Here’s a new ray of hope for those who are suffering from a cancer of the blood and bone marrow. Agios Pharmaceuticals, a small biotech company, just got its first cancer drug approved by the FDA. Called Idhifa, the drug is created to treat acute myelogenous leukemia.
Idhifa or enasidenib treats the cancer of the blood and bone marrow by starving out cancer cells. It is created specifically for AML patients with an IDH2 mutation. AML is generally found in older people, usually those you are 45-years-old and above.
Business Insider explained that cancer cells have a different metabolism than normal cells, and knowing that metabolic process helps in targeting the cancer cells while leaving the healthy ones untouched.
0 comments :
Post a Comment